Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry
Articolo
Data di Pubblicazione:
2021
Abstract:
To investigate survival of IL-1 inhibitors in monogenic autoinflammatory disorders (mAID) through drug retention rate (DRR) and identify potential predictive factors of drug survival from a real-life perspective.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
IL-1; anakinra; canakinumab; innovative biotechnologies; monogenic autoinflammatory disorders; personalized medicine; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Female; Follow-Up Studies; Hereditary Autoinflammatory Diseases; Humans; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Male; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult; Registries
Elenco autori:
Sota, Jurgen; Rigante, Donato; Cimaz, Rolando; Cattalini, Marco; Frassi, Micol; Manna, Raffaele; Sicignano, Ludovico Luca; Verrecchia, Elena; Aragona, Emma; Maggio, Maria Cristina; Lopalco, Giuseppe; Emmi, Giacomo; Parronchi, Paola; Cauli, Alberto; Wiesik-Szewczyk, Ewa; Hernández-Rodríguez, José; Gaggiano, Carla; Tarsia, Maria; Mourabi, Mariam; Ragab, Gaafar; Vitale, Antonio; Fabiani, Claudia; Frediani, Bruno; Lamacchia, Vittoria; Renieri, Alessandra; Cantarini, Luca
Link alla scheda completa:
Pubblicato in: